Metropolis Healthcare Ltd, one of the leading diagnostics companies in India, by revenue, as of March 31, 2018, according to a Frost & Sullivan report, has filed an offer document with the Securities Exchange Board of India (Sebi) to launch an Initial Public Offering (IPO).
The objects of the offer are to achieve the benefits of listing the equity shares on the stock exchanges and for the offer for sale.
The company’s IPO comprises an offer of up to 15,269,684 equity shares of face value of Rs2 each (the “Equity Shares”) for cash at a price per equity share; consisting of an offer for sale of up to 5,017,868 equity shares by Dr. Sushil Kanubhai Shah (the “Promoter Selling Shareholder”) and up to 10,251,816 equity shares by CA Lotus Investments (the “Investor Selling Shareholder”).
The offer Includes a reservation of up to 300,000 equity shares for subscription by eligible employees.
The Book Running Lead Managers (“BRLMs) are JM Financial Limited, Credit Suisse Securities (India) Private Limited, Goldman Sachs (India) Securities Private Limited, HDFC Bank Limited, and Kotak Mahindra Capital Company Limited
The equity shares offered through the issue are proposed to be listed on the BSE and the NSE.